key: cord-0782718-pf2tnn9j
authors: Marques, Nelson Pereira; Silveira, Denise Maria M.; Marques, Nádia Carolina Teixeira; Martelli, Daniella Reis Barbosa; Oliveira, Eduardo A.; Martelli-Júnior, Hercílio
title: Cancer diagnosis in Brazil in the COVID-19 era
date: 2021-01-07
journal: Semin Oncol
DOI: 10.1053/j.seminoncol.2020.12.002
sha: fa1cfbce7c7e1e019a79354e1c70d25c7dbbe9bf
doc_id: 782718
cord_uid: pf2tnn9j

The comprehensive care and treatment for cancer patients in Brazil, regulated by the National Cancer Prevention and Control Policy, is provided by Brazilian Unified Healthcare System (SUS) in certified health institution. Due the COVID-19 pandemic, several restrictive measures have been implemented by the State federation's governments, and cancer diagnosis reference centers were also impacted by these measures. Thus, this study aimed to compare SUS-oriented cancer diagnosis in Brazil before and during the pandemic so far. The average number of cancer diagnoses has dropped considerably in all Brazilian Regions since the pandemic period started. The number of new cancer cases has plunged in all regions, ranged from −24.3% in the North to −42.7% in Northeast region. The overall Brazilian average deficit reached 35.5%, corresponding to about 15,000 undiagnosed cases of cancer monthly. The pandemic period has dramatically reduced the diagnosis of new cases of cancer in Brazil, since consultations in public health services were compromised by restrictive measures. Therefore, effective measures must be urgently put in action in order to minimize the damage, and consequently, the negative health impacts caused by the COVID-19 pandemic in the care of cancer patients.

The coronavirus disease , caused by the virus SARS- 2 CoV-2, was detected in Brazil on February 26, 2020 approximately 3 2 months after the first case have been reported in China. The first 4 death by COVID-19 in Brazil occurred on March 17, 2020 when 5 the disease had already turned into a pandemic [1] . The COVID- 6 19 pandemic has severely impacted health systems worldwide [2] , 7 affecting the care of various chronic diseases, including cancer di- 8 agnosis and treatment [3 , 4] . Recent studies have shown the effects 9 of COVID-19 on health professionals' routinely responsible for di- 10 agnosing and treating patients with cancer [5] [6] [7] [8] . A set of security 11 measures has been proposed to relieve this problem, even so it is 12 an alarming situation [9] [10] [11] . 13 Brazilian Unified Healthcare System 14 The Brazilian Unified Healthcare System (Sistema Único de 15 Saúde, SUS) is the world largest universal healthcare system, 16 funded by federal, state, and municipal resources and serves 17 over 209,0 0 0 million inhabitants ( https://censo2010.ibge.gov.br ) 18 (accessed in October 2020). Qualifying the service network and 19 guaranteeing access to users is a daily challenge faced by SUS 20 managers, whom, in 2011, developed the largest institutional eval- 21 uation program of its history, the Access and Quality Improve- articles [16] [17] [18] [19] [20] were selected for discussion in Table 1 . 73 

Coronavirus disease pan-155 demic is a real challenge for Brazil

COVID-19 and Italy: what next?

Implication of COVID-19 in oral oncol-160 ogy practices in Brazil, Canada, and the United States

Reduced demand for oral diag-163 nosis during COVID-19: a Brazilian center experience

Breast cancer and COVID-19 pan-166 demic in Brazil

Impact of COVID-19 on cancer patients: a review

COVID-19 and cancer in Cuba

Early impact of the COVID-19 pan-172 demic on paediatric câncer care in Latin America

A practical approach to the 175 management of cancer patients during the novel Coronavirus disease 2019 176 (COVID-19) Pandemic: an International Collaborative Group

Management of early breast cancer 179 during the COVID-19 pandemic in Brazil. Breast Cancer Re Treatment

Management of cervical cancer 182 patients during the COVID-19 pandemic: a challenge for developing countries

PMAQ -CEO external evalua-185 tion: revealing indicators for planning services. Pesq Bras Odontoped Clin In-186 tegr

Brazil's endan-188 gered postgraduate system

A country level analysis mea-191 suring the impact of government actions, country preparedness and socioe-192 conomic factors on COVID-19 mortality and related health outcomes. EClini-193 calMed 2020

Quarantine alone or in com-195 bination with other public health measures to control COVID-19: a rapid re-196 view

Cancer diagnostic rates during the 199 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: 200 an audit study from cellular pathology

Cancer diagnostic de-203 lay in northern and central Italy during the 2020 lockdown due to the Coron-204 avirus disease 2019 Pandemic

Changes in the number of US patients 207 with newly identified cancer before and during the Coronavirus Disease

Decreasing access to cancer diag-211 nosis and treatment during the COVID-19 pandemic in Poland

Impact of COVID-19 on cancer in Slovenia

Telemedicine in oncology and reim-216 bursement policy during COVID-19 and beyond

The authors would like to thank State Research Foundation-147 FAPEMIG, Minas Gerais, Brazil, the National Council for Scientific